Chestnut Hill Health System — Philadelphia, Pennsylvania

Chestnut Hill Health System is a clinical research site located in Philadelphia, Pennsylvania, United States 19118.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Chestnut Hill Health System has participated in 3 clinical trials.

Therapeutic areas: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), ETOP IBCSG Partners Foundation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

• Jefferson University Physicians (JUP) - Jefferson Pulmonary
• Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania
• Thomas Jefferson University Hospital /ID# 232614
• Thomas Jefferson University Hospital;Medical Oncology
• Thomas Jefferson Memorial Hospital
• Fox Chase Temple Cancer Center - Temple University
• University of Pennsylania, Perelman School of Medicine
• Thomas Jefferson University_Philadelphia
• Thomas Jefferson University Hospital, Cardiovascular Associates
• Thomas Jefferson University Honickman Center
• Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital
• Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chestnut Hill Health System?

Chestnut Hill Health System has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chestnut Hill Health System conducted?

Chestnut Hill Health System has 3 clinical trials on record. Their work covers Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma.

Is Chestnut Hill Health System accredited by Crixeo Clinical Trials?

Chestnut Hill Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chestnut Hill Health System?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.